Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/253957
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Privileged quinolylnitrones for the combined therapy of ischemic stroke and alzheimer’s disease |
Autor: | Alonso, José M. CSIC; Escobar-Peso, Alejandro CSIC ORCID; Palomino-Antolín, Alejandra; Diez-Iriepa, Daniel CSIC; Chioua, Mourad CSIC ORCID ; Martínez-Alonso, E.; Iriepa, I.; Egea, Javier; Alcázar, Alberto; Marco-Contelles, José CSIC ORCID | Palabras clave: | Alzheimer’s disease Ischemic stroke Multipotent drugs Neuroprotection Quinolylnitrones |
Fecha de publicación: | 2021 | Editor: | Molecular Diversity Preservation International | Citación: | Pharmaceuticals 14 (2021) | Resumen: | Cerebrovascular diseases such as ischemic stroke are known to exacerbate dementia caused by neurodegenerative pathologies such as Alzheimer’s disease (AD). Besides, the increasing number of patients surviving stroke makes it necessary to treat the co-occurrence of these two diseases with a single and combined therapy. For the development of new dual therapeutic agents, eight hybrid quinolylnitrones have been designed and synthesized by the juxtaposition of selected pharmacophores from our most advanced lead-compounds for ischemic stroke and AD treatment. Biological analyses looking for efficient neuroprotective effects in suitable phenotypic assays led us to identify MC903 as a new small quinolylnitrone for the potential dual therapy of stroke and AD, showing strong neuroprotection on (i) primary cortical neurons under oxygen–glucose deprivation/normoglycemic reoxygenation as an experimental ischemia model; (ii), neuronal line cells treated with rotenone/oligomycin A, okadaic acid or β-amyloid peptide Aβ25–35, modeling toxic insults found among the effects of AD. | Versión del editor: | http://dx.doi.org/10.3390/ph14090861 | URI: | http://hdl.handle.net/10261/253957 | DOI: | 10.3390/ph14090861 | Identificadores: | doi: 10.3390/ph14090861 issn: 1424-8247 |
Aparece en las colecciones: | (IQOG) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
pharmaceuticals-14-00861-v2.pdf | 1,54 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
4
checked on 25-abr-2024
WEB OF SCIENCETM
Citations
4
checked on 18-feb-2024
Page view(s)
41
checked on 27-abr-2024
Download(s)
58
checked on 27-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.